Note: Ingredients listed on restricted chemical lists
EC/CAS
215-481-4/1327-53-3
Name of the chemical
Diarsenic trioxide
Concentration
Proprietary
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
Balance
General Information
Revision date
2013-11-05
Product name
TRISENOX (arsenic trioxide) Injection
Product Synonyms
Arsenic Trioxide Injection (1 mg/mL); Aqueous Solution of Arsenic Trioxide
1.2.1 Relevant identified uses
Pharmaceutical
Manufacturer Name
TEVA
Emergency telephone
+39 02 93197 306, 1-800/424-9300, 01-703-527-3887
Icons in SDS
Company Information
company name
TEVA
e-mail address of the competent person responsible for the Safety Data Sheet
TevaSDSRequest@tevapharm.com
Section 2
SECTION 2: Hazards identification
Product definition
This product is a clear, colorless, odorless solution. Health WARNING! THIS PRODUCT CONTAINS A CYTOTOXIC AGENT. EXPOSURE BY ALL ROUTES OF EXPOSURE MUST BE AVOIDED. This product may be harmful by inhalation, skin contact or ingestion. Ingestion may cause serious adverse effects on the gastrointestinal, central nervous, blood, cardiovascular, and peripheral nervous systems or may be fatal. May cause fetal harm. These effects may be possible as a result of workplace exposure. Flammability Hazards: This product is not flammable. When involved in a fire, may decompose and produce irritating vapors and toxic compounds (including arsenic compounds, arsine and hydrogen chlorides). Reactivity Hazards This product is not reactive.
Environmental hazards
If large quantities are released to the adverse effects to plants and animals may occur. Emergency Recommendations Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.
